CHAPEL-EN-LE-FRITH, United Kingdom, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Concept Life Sciences, a leading contract research organization (CRO) serving the global life sciences and pharma industry, today ...
Neuroinflammation refers to an inflammatory reaction in the brain or spinal cord. It is driven by the production of molecules such as cytokines, chemokines, reactive oxygen species (ROS), and ...
In mice and human cell cultures, researchers showed that novel nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer's disease. In mice and ...
Neuroinflammation, a prolonged activation of the brain's immune system prompted by infections or other factors, has been linked to the disruption of normal mental functions. Past studies, for instance ...
New findings discussed at the latest Alzheimer’s Association International Conference (AAIC) highlight the risk factors associated with Alzheimer’s disease. Amongst the risks are inflammation-related ...
Coya Therapeutics Inc COYA reported results from an open-label proof-of-concept clinical study for low-dose interleukin 2 (ld IL-2) in patients with Alzheimer's disease (AD). The study enrolled eight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results